Evidence map›Paper›PMID 36825815›Full record

ArticleBioinformatics (Oxford, England)2023

Regularized adversarial learning for normalization of multi-batch untargeted metabolomics data.

Andrei Dmitrenko, Michelle Reid, Nicola Zamboni

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrei DmitrenkoETH Zürich, Institute of Molecular Systems Biology, Zürich 8093, Switzerland.
Michelle ReidETH Zürich, Institute of Molecular Systems Biology, Zürich 8093, Switzerland.
Nicola ZamboniETH Zürich, Institute of Molecular Systems Biology, Zürich 8093, Switzerland.ORCID 0000-0003-1271-1021

Funding

Strategic Focal Area Personalized Health and Related Technologies
6 · The paper itself

Abstract

motivationUntargeted metabolomics by mass spectrometry is the method of choice for unbiased analysis of molecules in complex samples of biological, clinical or environmental relevance. The exceptional versatility and sensitivity of modern high-resolution instruments allows profiling of thousands of known and unknown molecules in parallel. Inter-batch differences constitute a common and unresolved problem in untargeted metabolomics, and hinder the analysis of multi-batch studies or the intercomparison of experiments.

resultsWe present a new method, Regularized Adversarial Learning Preserving Similarity (RALPS), for the normalization of multi-batch untargeted metabolomics data. RALPS builds on deep adversarial learning with a three-term loss function that mitigates batch effects while preserving biological identity, spectral properties and coefficients of variation. Using two large metabolomics datasets, we showcase the superior performance of RALPS as compared with six state-of-the-art methods for batch correction. Further, we demonstrate that RALPS scales well, is robust, deals with missing values and can handle different experimental designs. AVAILABILITY AND IMPLEMENTATION: https://github.com/zamboni-lab/RALPS. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

MetabolomicsResearch DesignMass Spectrometry

Identifiers

PMID36825815
PMCPMC9978579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.